Biosimilarity Assessment and Chemistry Manufacture and Control consideration for Indication Extrapolation of Adalimumab Biosimilars

XU Gang-ling, SONG Li-Na, GE Yu-Mei, TANG Chong-qi, XIE Song-Mei

Chinese Pharmaceutical Journal ›› 2022, Vol. 57 ›› Issue (23) : 1967-1973.

PDF(956 KB)
PDF(956 KB)
Chinese Pharmaceutical Journal ›› 2022, Vol. 57 ›› Issue (23) : 1967-1973. DOI: 10.11669/cpj.2022.23.003

Biosimilarity Assessment and Chemistry Manufacture and Control consideration for Indication Extrapolation of Adalimumab Biosimilars

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 57(23): 1967-1973 https://doi.org/10.11669/cpj.2022.23.003

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(956 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉